Reboxetine
Alternative Names: Davedax; Edronax; FCE 20124; Irenor; Narebox; Norebox; Prolift; Reboxetine mesilate; Solvex; VestraLatest Information Update: 05 Nov 2023
At a glance
- Originator Pfizer
- Class Antidepressants; Ethers; Morpholines; Sleep disorder therapies; Small molecules
- Mechanism of Action Adrenergic receptor antagonists; Alpha 2 adrenergic receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Marketed Major depressive disorder
Most Recent Events
- 16 Apr 2003 Pharmacia Corporation has been acquired by, and merged into, Pfizer
- 21 May 2001 Pharmacia has received a "not-approvable" letter from the FDA for reboxetine
- 28 Nov 2000 Pharmacia and Janssen have terminated their agreement to copromote reboxetine